Observational studyThe journal of headache and pain2021

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study.

Katja Kollewe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.